VanEck Medical Robotics and Bionic Engineering UCITS ETF
16.13
CHF
0.34
CHF
2.18
%
NAV
Nettoinventarwert (NAV)
| 19.50 USD | 0.32 USD | 1.68 % |
|---|
| Vortag | 19.17 USD | Datum | 20.10.2026 |
VanEck Medical Robotics and Bionic Engineering UCITS ETF Kurs - 1 Jahr
Fundamentaldaten
| Fondsgesellschaft | VanEck Asset Management B.V. |
| Benchmark | MVIS Global Bionic Healthcare ESG |
| Kategorie | Branchen: Gesundheitswesen |
| Ausschüttung | Thesaurierend |
| Replikation | Physisch vollständig |
| Währung | USD |
| Fondsvolumen | 11’172’047.04 |
| Total Expense Ratio (TER) | 0.55 % |
| Auflagedatum | 02.12.2022 |
| Mindestanlage | 0.00 |
| Depotbank | State Street Custodial Services (Ireland) Limited |
| Zahlstelle |
Anlagepolitik
So investiert der VanEck Medical Robotics and Bionic Engineering UCITS ETF: The Fund’s investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to companies involved in the bionic implants industry including medical, dental, or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.